Back To Schedule
Wednesday, June 27 • 4:00pm - 5:00pm
#398: The Impact of Cell and Gene Therapy on the Payer System

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-18-687-L04-P; CME 1.00; IACET 1.00; RN 1.00

New therapeutic approaches are emerging, including gene therapies, cell therapies, gene editing technologies, and other tissue engineering therapies, that hold the promise of producing long-term and durable responses to serious conditions. Despite their great potential, a key question is how these therapies will impact the payer and reimbursement system due to their potentially high up-front costs within the traditional fee-for-service payment model. This session will focus on the need for a combined stakeholder approach to understand the pipeline of future therapies, to achieve partnerships across sectors, to explore how gene and cell therapies might impact the current payer and reimbursement system, and to address both access and affordability. The session will also present a paper, developed by the Duke-Margolis Value-Based Payment Consortium that considers potential benefits and challenges of proposed value-based payment approaches that have the potential to align payers, manufacturers, and providers towards greater value.

Learning Objectives

Discuss cell and gene therapies and the differences between therapeutics; Examine how these therapies impact models for reimbursement and payment within the current fee-for-service model; Discuss ongoing efforts to explore new financial mechanisms and value-based payment models.


Marianne Hamilton Lopez, PhD, MPA


Cell and Gene Therapy Development and the Impact on the Payer System
Dan Tierno, MA, MBA

avatar for Marianne Hamilton Lopez

Marianne Hamilton Lopez

Research Director, Value-Based Payment Reform, Duke-Margolis Center For Health Policy, United States
Marianne Hamilton Lopez, PhD, MPA is Research Director of Value-Based Payment Reform at the Duke-Robert J. Margolis, MD, Center for Health Policy. She focuses on value-based payment models for medical products; oversees a multi-stakeholder Consortium; and partners with faculty and... Read More →
avatar for Dan Tierno

Dan Tierno

Associate Director, Global Clinical Data Sciences and Analytics, Bayer
Mr. Dan Tierno has over 20 years of experience in the pharmaceutical and biotech industry, specializing in drug development, data sciences and analytics for clinical trials, and commercialization of novel small molecule and cell based therapeutics. Mr. Tierno has spoken on training... Read More →

Wednesday June 27, 2018 4:00pm - 5:00pm EDT
Room 204AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  12: Value-Access, Forum